SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Allergan
Allergan
Page 3 of 6
Health
Teva Says Its Deal to Buy Allergan’s Generics Business Will Close ‘Any Time’
By
Reuters
July 13, 2016
Finance
Carl Icahn Recently Bought a ‘Large Position’ in Allergan
By
Sy Mukherjee
May 31, 2016
Finance
Allergan Is Buying Back Up to $10 Billion in Stock
By
Reuters
and
Fortune Editors
May 10, 2016
Finance
These Biopharma Companies Are the World’s Top Shareholder Value Creators
By
Sy Mukherjee
May 3, 2016
Health
Allergan Struck a $3.3 Billion Alzheimer’s Drug Deal Right After Its Pfizer Merger Collapsed
By
Sy Mukherjee
April 7, 2016
Health
Pfizer and Allergan Scrap $160 Billion Deal
By
Reuters
April 6, 2016
Finance
Pfizer, Allergan to Mutually Terminate Merger
By
Reuters
April 6, 2016
Finance
Wall Street Is Betting the Pfizer-Allergan Deal Won’t Happen
By
Jen Wieczner
April 5, 2016
Leadership
Here’s Why Allergan Shares Are Tanking
By
Reuters
April 5, 2016
Health
Why Teva’s $40 Billion Deal for Allergan’s Generic Drugs Is Being Delayed
By
Sy Mukherjee
March 16, 2016
Finance
Here’s How Much More Pfizer Could Save in Taxes With Allergan Deal
By
Jen Wieczner
February 26, 2016
Health
Eli Lilly Just Lost the Latest Round in its Patent Battle
By
Reuters
February 12, 2016
Finance
Biotech Stocks Crashed and Nobody Knows Why
By
Jen Wieczner
January 29, 2016
Health
Celgene Settles U.S. Patent Litigation for Revlimid
By
Reuters
and
Aaron Task
December 23, 2015
Finance
2015 Is Now the Biggest Year Ever for M&A
By
Chris Matthews
December 4, 2015
Most Popular
Retail
Walmart and Target are allegedly forcing employees to remove tags on apparel to make it easier to jack up prices based...
By
Erin Cabrey
and
Retail Brew
Economy
Ray Dalio says 'most people are silent' because they're afraid to talk about what's really happening with the U.S....
By
Dave Smith
Success
Unemployed graduates are flocking to this business degree to stand out in the current job market. Unlike most MBAs it...
By
Emma Burleigh